Anika Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil falls almost 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Anika Therapeutics (ANIK) Tops Q1 EPS
May 7, 2020 5:06 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of $0.45, $0.51 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $35.4 million versus the consensus estimate of $31.53 million.
Anika delivered solid first quarter results and made significant progress towards advancing our strategic plan, including... More
